Therefore, ABCG2/BCRP as well as MDR1/ABCB1 plays a significant role in drug resistance, and inhibitors for ABCG2/BCRP may enhance the outcome of cancer chemotherapy. This evidence concerns the gene ABCB1 and cancer.